109 — Detroit, Michigan

109 is a clinical research site located in Detroit, Michigan, United States 48202.

Crixeo Health Trust Score: 57/100 (POOR). This profile has not yet been claimed by the site owner.

109 has participated in 1 clinical trials.

Therapeutic areas: Abscess, Wound Infection, Surgical Site Infection.

Sponsors: Durata Therapeutics Inc., an affiliate of Allergan plc.

Sponsor Feasibility Report

Trust Score: 57/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for 109?

109 has a Crixeo Trust Score of 57/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has 109 conducted?

109 has 1 clinical trials on record. Their work covers Abscess, Wound Infection, Surgical Site Infection.

Is 109 accredited by Crixeo Health?

109 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about 109?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.